Abduction Based Drug Target Discovery Using Boolean Control Network
暂无分享,去创建一个
[1] Ruth Nussinov,et al. Structure and dynamics of molecular networks: A novel paradigm of drug discovery. A comprehensive review , 2012, Pharmacology & therapeutics.
[2] R. Berro,et al. Functional consequences of cyclin D1/BRCA1 interaction in breast cancer cells , 2007, Oncogene.
[3] Neelu Puri,et al. Mechanism of Resistance and Novel Targets Mediating Resistance to EGFR and c-Met Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer , 2015, PloS one.
[4] Kyoung-Mee Kim,et al. The Impact of Concomitant Genomic Alterations on Treatment Outcome for Trastuzumab Therapy in HER2-Positive Gastric Cancer , 2015, Scientific Reports.
[5] K. Strimbu,et al. What are biomarkers? , 2010, Current opinion in HIV and AIDS.
[6] U. Moll,et al. The MDM2-p53 interaction. , 2003, Molecular cancer research : MCR.
[7] M. Vidal,et al. Edgetic perturbation models of human inherited disorders , 2009, Molecular systems biology.
[8] Filippos Koinis,et al. Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy , 2014, Breast Cancer Research.
[9] W. Quine. On Cores and Prime Implicants of Truth Functions , 1959 .
[10] Alan Veliz-Cuba,et al. Identification of control targets in Boolean molecular network models via computational algebra , 2015, BMC Systems Biology.
[11] K. White,et al. Widespread genetic epistasis among cancer genes , 2014, Nature Communications.
[12] P. Phillips. Epistasis — the essential role of gene interactions in the structure and evolution of genetic systems , 2008, Nature Reviews Genetics.
[13] W. Foulkes,et al. BRCA1 and BRCA2: 1994 and beyond , 2004, Nature Reviews Cancer.
[14] Alan Ashworth,et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy , 2005, Nature.
[15] Livia Perfetto,et al. SIGNOR: a database of causal relationships between biological entities , 2015, Nucleic Acids Res..
[16] Z. Yao,et al. DNA-independent PARP-1 activation by phosphorylated ERK2 increases Elk1 activity: a link to histone acetylation. , 2007, Molecular cell.
[17] Sudhir Gupta,et al. Molecular signaling in death receptor and mitochondrial pathways of apoptosis (Review). , 2003, International journal of oncology.
[18] Ana Lluch,et al. Molecular biology in breast cancer: intrinsic subtypes and signaling pathways. , 2012, Cancer treatment reviews.
[19] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[20] Larry Rubinstein,et al. Poly(ADP-ribose) polymerase inhibition enhances p53-dependent and -independent DNA damage responses induced by DNA damaging agent , 2011, Cell cycle.
[21] Hui Tian,et al. BRCA1 physically associates with p53 and stimulates its transcriptional activity , 1998, Oncogene.
[22] Huitu Liu,et al. MAPK signal pathways in the regulation of cell proliferation in mammalian cells , 2002, Cell Research.
[23] J. Garber,et al. PARP inhibitors in the management of breast cancer: current data and future prospects , 2015, BMC Medicine.
[24] G. Yarrington. Molecular Cell Biology , 1987, The Yale Journal of Biology and Medicine.
[25] Pierre Marquis,et al. Extending abduction from propositional to first-order logic , 1991, FAIR.
[26] C. Deng,et al. BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution , 2006, Nucleic acids research.
[27] Dan Li,et al. BRCA1 regulation of epidermal growth factor receptor (EGFR) expression in human breast cancer cells involves microRNA-146a and is critical for its tumor suppressor function , 2014, Oncogene.
[28] M. Vidal. A unifying view of 21st century systems biology , 2009, FEBS letters.
[29] S. Khatri,et al. Application of Max-SAT-based ATPG to optimal cancer therapy design , 2012, BMC Genomics.
[30] Chad J. Miller,et al. Kinome-wide Decoding of Network-Attacking Mutations Rewiring Cancer Signaling , 2015, Cell.
[31] Minoru Kanehisa,et al. KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..
[32] Clara Pizzuti. Computing prime implicants by integer programming , 1996, Proceedings Eighth IEEE International Conference on Tools with Artificial Intelligence.
[33] Franck Delaplace,et al. Abductive Network Action Inference for Targeted Therapy Discovery , 2018, SASB.
[34] B. Kholodenko,et al. The dynamic control of signal transduction networks in cancer cells , 2015, Nature Reviews Cancer.
[35] Fuminori Tsuruta,et al. The Phosphatidylinositol 3-Kinase (PI3K)-Akt Pathway Suppresses Bax Translocation to Mitochondria* , 2002, The Journal of Biological Chemistry.
[36] C. Peirce,et al. Five Hundred and Eighty-First Meeting. April 9, 1867. Monthly Meeting; On the Natural Classification of Arguments , 1865 .
[37] L. Cantley,et al. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[38] Andrea Ciliberto,et al. Steady States and Oscillations in the p53/Mdm2 Network , 2005, Cell cycle.
[39] Tak W. Mak,et al. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis , 2006, Nature Reviews Cancer.
[40] W. Kaelin. The Concept of Synthetic Lethality in the Context of Anticancer Therapy , 2005, Nature Reviews Cancer.
[41] L. Mayo,et al. The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network. , 2002, Trends in biochemical sciences.
[42] P. Rothberg,et al. Oncogenes and cancer. , 1983, Cancer investigation.
[43] Benjamin J. Raphael,et al. Mutational landscape and significance across 12 major cancer types , 2013, Nature.
[44] M. Pagano,et al. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. , 1993, Genes & development.
[45] J. McCubrey,et al. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy , 2003, Leukemia.
[46] M. Malanga,et al. Poly(ADP-ribose) Binds to Specific Domains of p53 and Alters Its DNA Binding Functions* , 1998, The Journal of Biological Chemistry.
[47] P. Mullan,et al. The role of BRCA1 in transcriptional regulation and cell cycle control , 2006, Oncogene.
[48] M. Barančík,et al. Mitogen-activated protein kinases and their role in regulation of cellular processes. , 2002, General physiology and biophysics.
[49] J. Alao,et al. Molecular Cancer BioMed Central Review The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention , 2007 .
[50] Tim Beißbarth,et al. Boolean ErbB network reconstructions and perturbation simulations reveal individual drug response in different breast cancer cell lines , 2014, BMC Systems Biology.
[51] R. Price,et al. Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data , 2015, BMC Medicine.
[52] Réka Albert,et al. Cell Fate Reprogramming by Control of Intracellular Network Dynamics , 2014, PLoS Comput. Biol..
[53] Hai Hu,et al. Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice , 2011, Breast Cancer Research.
[54] T. Mak,et al. Regulation of PTEN transcription by p53. , 2001, Molecular cell.
[55] A. Barabasi,et al. Interactome Networks and Human Disease , 2011, Cell.
[56] Akif Uzman,et al. Molecular Cell Biology (4th edition): Harvey Lodish, Arnold Berk, S. Lawrence Zipursky, Paul Matsudaira, David Baltimore and James Darnell; Freeman & Co., New York, NY, 2000, 1084 pp., list price $102.25, ISBN 0-7167-3136-3 , 2001 .
[57] Aniruddha Datta,et al. Systems biology Advance Access publication December 30, 2010 Cancer therapy design based on pathway logic , 2022 .
[58] K. Kinzler,et al. Cancer Genome Landscapes , 2013, Science.
[59] John Calvin Reed,et al. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene , 1995, Cell.